Watch LYEL. Know when insiders buy.
One email the day a filing lands. Free.
LYEL
Lyell Immunopharma, Inc.
9.70
+0.90 +10.23%
USD · close Oct 20
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
48
WATCH · insiders 41, shorts 54
Insiders, 90 days
−$197K
net selling · 0 buys, 5 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $237.7MP/E —DIV YIELD —FCF YIELD -56.36%REV TTM $27K −55.0%NET INCOME −$248.5MNET CASH —52W 7.51 – 38.60SEC XBRL · TTM TO Invalid Date
Insider trading
−$197K
Net, 90 days
0 / 5
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 12 | Oct 13 | Aguirre Jarrad Mattieu · Chief Medical Officer | Sell | 422 | $8.63 | $4K |
| Sep 10 | Sep 10 | Shook David · Chief Medical Officer | Sell | 500 | $12.70 | $6K |
| Aug 21 | Aug 25 | Seely Lynn · President and CEO | Sell | 9,589 | $15.54 | $149K |
| Aug 21 | Aug 25 | Lee Gary K. · Chief Scientific Officer | Sell | 1,457 | $15.54 | $23K |
| Aug 21 | Aug 25 | Hill Stephen J. · Chief Operating Officer | Sell | 989 | $15.54 | $15K |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.